0001209191-21-013228.txt : 20210223
0001209191-21-013228.hdr.sgml : 20210223
20210223163339
ACCESSION NUMBER: 0001209191-21-013228
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210218
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGahan Keith M
CENTRAL INDEX KEY: 0001743778
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 21666078
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-18
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001743778
McGahan Keith M
11500 S. EASTERN AVE.
SUITE 240
HENDERSON
NV
89052
0
1
0
0
Chief Legal Officer
Common Stock, $0.001 par value
2021-02-18
4
A
0
110309
0.00
A
354807
D
Common Stock, $0.001 par value
2021-02-19
4
S
0
3295
3.637
D
351512
D
Common Stock, $0.001 par value
2021-02-22
4
S
0
4000
3.73
D
347512
D
Common Stock, $0.001 par value
6250
I
By 401(k) Plan
Stock Option (Right to Buy)
3.56
2021-02-18
4
A
0
133708
0.00
A
2031-02-18
Common Stock
113708
113708
D
Stock Appreciation Right
3.56
2021-02-18
4
A
0
314213
0.00
A
2031-02-18
Common Stock
314213
314213
D
One third of the aggregate amount of restricted shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
One third of the aggregate amount of option shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
One third of the aggregate amount of stock appreciation rights shall vest on each of February 18, 2022, 2023 and 2024, respectively.
/s/ Kurt A. Gustafson, attorney-in-fact for Keith M. McGahan
2021-02-23